Phase I clinical study of personalized neoantigen peptides vaccine for solid tumors
Latest Information Update: 01 Jun 2020
At a glance
- Drugs HJ N 001 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 01 Jun 2020 New trial record